Icon Group acquire Epic Digital to enhance patient care


Ensuring patients can access the highest quality cancer care, no matter their postcode, is an expected benefit of the acquisition of Epic Digital by Icon Group.

Rural and remote Australians have significantly poorer outcomes from a cancer diagnosis than their city counterparts, so finding new ways to connect with patients and deliver health care is important to improve health in the bush.

Icon Group CEO Mark Middleton says technology advances are allowing health care practitioners to communicate with patients and customers living in the further reaches of Australia.

“It is innovative approaches like Epic Digital’s that enable us to deliver care where patients are, whether that is metro, regional or rural. More than an increased accessibility, their solutions also empower patients to take charge of their health,” he said.

Better management of an individual’s condition can reduce hospital readmission, prevent adverse events, and in disease prevention and reduce costs.

Epic Digital Managing Director, Cathie Reid, is also delighted to team up with Icon Group as both companies are committed to delivering exceptional patient care.

“Epic Digital’s products are designed to improve access to information for both patients and care givers, while at the same time increasing the efficiency of operations.”

One of Epic Digital’s projects is working with Microsoft Health in their Early Adopter Program, to develop an application that overlays real time data collected using Microsoft’s Health Band with medical data currently available to health professionals.

It’s anticipated that combining this known data which takes the form of treatment plans, medications and symptoms, with real time heart rate monitoring, motion sensing and temperature will allow better monitoring of post treatment impact, allowing for proactive intervention when required.

Epic Digital’s products will complement and expand the services Icon Group already provides to its patients, said Ms Reid.


Comments are closed.